Form 8-K - Current report:
SEC Accession No. 0000950170-25-015847
Filing Date
2025-02-07
Accepted
2025-02-07 07:06:45
Documents
15
Period of Report
2025-02-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cgc-20250207.htm   iXBRL 8-K 51897
2 EX-99.1 cgc-ex99_1.htm EX-99.1 627197
3 GRAPHIC img62664582_0.jpg GRAPHIC 913017
4 GRAPHIC img62664582_1.jpg GRAPHIC 13543
5 GRAPHIC img62664582_2.jpg GRAPHIC 913017
  Complete submission text file 0000950170-25-015847.txt   3370339

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgc-20250207.xsd EX-101.SCH 30851
17 EXTRACTED XBRL INSTANCE DOCUMENT cgc-20250207_htm.xml XML 4505
Mailing Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8
Business Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8 855-558-9333
Canopy Growth Corp (Filer) CIK: 0001737927 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38496 | Film No.: 25599270
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)